Schizophrenia

Overview of Schizophrenia as a Clinical Exemplar

  • Definition of Exemplar: Within the context of this nursing curriculum, an exemplar is defined as a clear, well-defined example used specifically to guide learning and provide a framework for understanding complex disorders.
  • Core Mechanisms: Schizophrenia is driven by a complex interaction of various mechanisms across the lifespan, including:     * Genetic Vulnerability: The primary precursor and a significant risk factor.     * Neurodevelopmental Factors: Issues in the development of brain structures.     * Neurochemical Factors: Imbalances in neurotransmitters.     * Structural Factors: Physical changes in brain anatomy.     * Environmental Factors: External triggers and stressors.

Clinical Characteristics and Onset

  • Prevalence:     * Approximately 1%1\% of the population is affected.     * This equates to roughly 3×1063 \times 10^6 individuals in America according to the course textbook.
  • Age of Onset:     * Typically occurs in late adolescence or early adulthood.     * Men: Peak incidence occurs between the ages of 1515 and 25 years25\,\text{years}.     * Women: Onset typically occurs later than in men.     * Children: Schizophrenia rarely manifests in children.
  • Biological Findings (Evidence-Based):     * Neuroanatomy: Evidence from Chapter 16 indicates decreased brain tissue and a decrease in cerebrospinal fluid (CSF\text{CSF}).     * Neurotransmitters: Dopamine is the primary neurotransmitter connected to the pathology of schizophrenia.     * Etiological Theories: Includes brain dysfunction, neurochemical imbalances, and potential viral causes.
  • Impact on Quality of Life: The disorder causes maladaptive behaviors and significant cognitive deficits, leading to diminished function in society and occupation compared to neurotypical individuals.

Symptomatology and Categories of Signs

  • Positive Symptoms (Hard Symptoms):     * These involve behaviors that are added to the personality and are often the basis for diagnosis.     * Delusions: False, firmly held beliefs contrary to reality and resistant to disconfirming evidence.         * Persecutory Delusions: Belief that one is being targeted or harassed.         * Thought Insertion: Belief that thoughts are being placed into one's mind.         * Thought Broadcasting: Belief that others can hear one's thoughts.         * Grandiose Delusions: Exaggerated sense of importance or power.         * Ideas of Reference: Belief that coincidental events have a strong personal significance.     * Hallucinations: Sensory perceptions without external stimuli.         * Auditory: Hearing voices (the most common hallmark).         * Visual: Seeing things that are not there.         * Tactile: Feeling sensations on the skin, such as things crawling on the body.
  • Negative Symptoms (Soft Symptoms):     * These involve behavioral deficits or things taken away from the personality.     * Includes social withdrawal, flat affect (loss of physical emotional expression), and a lack of interest in school or hygiene (negligence).     * Mechanical Cause: Often associated with long-term use of antipsychotic medications where dopamine inhibition causes a "mask-like" appearance.
  • Cognitive Deficits:     * Deferred attention.     * Diminished working memory.     * Diminished executive function.

The Nursing Process (ADPIE) in Schizophrenia

  • Assessment:     * History: Previous hospitalizations, onset of symptoms, and history of violence/aggression toward self, others, or property.     * Mental Status Examination (MSE): A critical tool focusing on:         * Appearance and Behavior.         * Speech and Thought Content/Process (e.g., tangential thinking or disorganized thoughts).         * Mood and Affect.         * Cognition, Insight, and Judgment.     * Risk Assessment: Determining if the patient is suicidal, homicidal, or suffering from negligence/self-neglect.
  • Diagnosis:     * Identifying risks such as self-harm related to psychotic ideation.     * Recognizing impairment in social interaction and ineffective coping.
  • Outcomes (SMART Goals):     * Specific: Patient will remain free from self-harm during the clinical day.     * Measurable: Patient will identify two coping strategies for managing auditory hallucinations.     * Achievable/Realistic: Family will demonstrate understanding of medication side effects before discharge.     * Time-bound: Defined intervals for goal achievement.
  • Implementation:     * Psychosocial/Behavioral Interventions: Using positive reinforcement and building a trusting relationship.     * Safety Measures: De-escalation, environmental modifications (removal of harmful objects), and seclusion if necessary (using the least restrictive method).     * Health Promotion: Encouraging smoking cessation (as many patients use nicotine for comfort), managing obesity, and promoting exercise and correct nutrition.
  • Evaluation:     * Determining if symptoms are disappearing.     * Assessing if the patient understands their medication regimen and has the functioning abilities needed for community placement.

Pharmacology and Nursing Management

  • First-Generation Antipsychotics (Conventional):     * Examples: Fluphenazine, Haloperidol.     * Mechanism: Dopamine antagonists.     * Target: Effectively decrease positive symptoms but have no observable effect on negative symptoms.
  • Second-Generation Antipsychotics (Atypical):     * Examples: Risperidone, Paliperidone, Olanzapine, Clozapine.     * Target: Help with negative symptoms and slow their progression.     * Warning: Increased mortality rates in elderly patients with dementia-related psychosis.
  • Third-Generation Antipsychotics:     * Example: Aripiprazole.
  • Special Considerations for Clozapine:     * Risk of Agranulocytosis: Potential failure of bone marrow to produce adequate white blood cells (WBC\text{WBC}).     * Monitoring: Requires weekly blood work initially, then every two weeks, eventually moving to monthly or every six months.     * Seizure Risk: Occurs in approximately 1%1\% of patients.
  • Side Effects and Nursing Implications:     * Extrapyramidal Side Effects (EPS): Movement disorders including akathisia (restlessness), acute dystonia, and pseudo-parkinsonism (shuffling gait).     * Tardive Dyskinesia: Late-onset, often irreversible movement disorder; dose reduction may slow the problem.     * Neuroleptic Malignant Syndrome (NMS): A medical emergency characterized by:         * Muscle rigidity.         * High fever.         * Increased Creatinine Kinase (CK\text{CK}) enzymes.         * Leukocytosis (increased white blood cell count).     * Anticholinergic Side Effects: Described as "can't spit, can't pee" (dry mouth, urinary retention, low blood pressure). Often treated by adding specific anticholinergic medications.     * Non-Neuroleptic Side Effects: Weight gain, sedation, and photosensitivity (Table 16.2).
  • Screening Tools:     * AIMS (Abnormal Involuntary Movement Scale): Done every 3−6 months3-6\,\text{months} by psychiatrists to monitor for EPSEPS.     * Simpson-Angus Scale: Used for assessing extrapyramidal symptoms (Box 16.2).

Legal, Ethical, and Cultural Considerations

  • Admission Status: Voluntary vs. Involuntary admission.
  • Patient Rights: Confidentiality, autonomy (balancing respect with beneficence), and the right to the least restrictive environment.
  • Duty to Warn: The nurse's legal obligation to warn others if a patient threatens them and there is immediate danger.
  • Mandatory Reporting: Requirement to report suspected abuse in children or the elderly.
  • Decision-Making Capacity: Evaluating if the patient can make their own healthcare decisions.
  • Cultural Sensitivity:     * Use of interpreters for non-English speakers.     * Understanding "Cultural Bound Syndromes" (Page 259).     * Addressing the stigma associated with mental illness in different cultures.     * Recognizing that some cultures view "voices" as spiritual communication rather than disease.

Collaborative and Evidence-Based Practice

  • Assertive Community Treatment (ACT): Programs that assist with medication management, housing, and skills training to prevent relapse.
  • Cognitive Behavioral Therapy (CBT) for Psychosis: Highly effective for symptom reduction and improving coping skills.
  • Trauma-Informed Care: Settings designed to minimize re-traumatization and address root causes of distress.
  • Lifespan Interventions:     * Prenatal: Monitoring medications for pregnant patients.     * School-Age: Addressing anti-bullying and social-emotional learning.     * Elderly: Managing late-onset schizophrenia and housing needs.
  • Community Referral: Ensuring follow-up appointments and discharge to stable environments to prevent homelessness and ER relapses.

Professional Nursing Self-Awareness

  • Recognition of Feelings: Nurses must acknowledge their own fears or discomfort when dealing with paranoid or suspicious patients.
  • Trust Building: Recognizing that patient paranoia is a symptom of the disease, not a personal attack on the nurse.
  • Role of Advocacy: The nurse acts as a stand-up advocate for the patient’s treatment plan, whether in the hospital or the community.